KEGG   DRUG: Prasinezumab
Entry
D11420                      Drug                                   
Name
Prasinezumab (USAN/INN)
Formula
C6452H9994N1718O2014S44
Exact mass
145174.0137
Mol weight
145263.63
Sequence
(Heavy chain)
EVQLVESGGG LVQPGGSLRL SCAASGFTFS NYGMSWVRQA PGKGLEWVAS ISSGGGSTYY
PDNVKGRFTI SRDDAKNSLY LQMNSLRAED TAVYYCARGG AGIDYWGQGT LVTVSSASTK
GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS
LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKRVEPKSCD KTHTCPPCPA PELLGGPSVF
LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP REEQYNSTYR
VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVYTL PPSREEMTKN
QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLYSKLT VDKSRWQQGN
VFSCSVMHEA LHNHYTQKSL SLSPGK
(Light chain)
DIQMTQSPSS LSASVGDRVT ITCKSIQTLL YSSNQKNYLA WFQQKPGKAP KLLIYWASIR
KSGVPSRFSG SGSGTDFTLT ISSLQPEDLA TYYCQQYYSY PLTFGGGTKL EIKRTVAAPS
VFIFPPSDEQ LKSGTASVVC LLNNFYPREA KVQWKVDNAL QSGNSQESVT EQDSKDSTYS
LSSTLTLSKA DYEKHKVYAC EVTHQGLSSP VTKSFNRGEC
(Disulfide bridge: H22-H96, H143-H199, H219-L220, H225-H'225, H228-H'228, H260-H320, H366-H424, H'22-H'96, H'143-H'199, H'219-L'220, H'260-H'320, H'366-H'424, L23-L94, L140-L'200, L'23-L'94, L'140-L'200)
  Type
Peptide
Efficacy
Antiparkinsonian, Anti-synuclein alpha antibody
  Type
Monoclonal antibody
Comment
Treatment of Parkinson's disease
Target
SNCA [HSA:6622] [KO:K04528]
  Pathway
hsa05012  Parkinson disease
Brite
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Cellular process
   Membrane trafficking
    SNCA
     D11420  Prasinezumab (USAN/INN)
Other DBs
CAS: 1960462-19-4
PubChem: 384585397
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system